Skip to Content

Coloplast A/S ADR CLPBY

Morningstar Rating
$13.55 +0.04 (0.30%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Upgrading Coloplast to a Wide Economic Moat Rating

Based in Denmark, Coloplast is a leader in global ostomy and continence care. The firm has made inroads into the concentrated urology and fragmented woundcare markets, but it remains a peripheral player there. In contrast, Coloplast has a long record of consistent and meaningful innovation in ostomy and continence care that has led to a dominant position in Europe. Since 2008, the firm has done an admirable job of trimming its cost structure as it focused on profitable growth. After shifting the majority of its production to Hungary, China, and Costa Rica, Coloplast now enjoys a gross margin that beats that of rival Convatec by more than 1,500 basis points. Currently, Coloplast is altering its emphasis to enhance growth by entering new geographies, with an emphasis on the United States.

Price vs Fair Value

CLPBY is trading at a 4% discount.
Price
$13.54
Fair Value
$74.10
Uncertainty
Medium
1-Star Price
$69.82
5-Star Price
$5.28
Economic Moat
Svzhs
Capital Allocation
Ltgprqtxwm

Bulls Say, Bears Say

Bulls

Because of aging populations in developed countries, the incidence of colorectal disease is growing. Independent of age, the incidence of inflammatory bowel disease is also on the rise.

Bears

Now that Coloplast has already shifted most of its manufacturing to low-cost geographies, gains in gross margin may not be so easy to achieve.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CLPBY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$13.51
Day Range
$13.4913.58
52-Week Range
$9.9014.77
Bid/Ask
$13.30 / $13.70
Market Cap
$30.46 Bil
Volume/Avg
69,444 / 111,928

Key Statistics

Price/Earnings (Normalized)
42.28
Price/Sales
8.11
Dividend Yield (Trailing)
2.24%
Dividend Yield (Forward)
2.24%
Total Yield
2.24%

Company Profile

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
15,751

Competitors

Valuation

Metric
CLPBY
CTEC
BSX
Price/Earnings (Normalized)
42.2823.5333.47
Price/Book Value
13.574.465.22
Price/Sales
8.113.447.05
Price/Cash Flow
33.6019.7630.67
Price/Earnings
CLPBY
CTEC
BSX

Financial Strength

Metric
CLPBY
CTEC
BSX
Quick Ratio
0.350.790.63
Current Ratio
0.531.621.32
Interest Coverage
9.203.218.41
Quick Ratio
CLPBY
CTEC
BSX

Profitability

Metric
CLPBY
CTEC
BSX
Return on Assets (Normalized)
12.14%7.44%8.92%
Return on Equity (Normalized)
47.39%16.69%16.33%
Return on Invested Capital (Normalized)
16.96%10.90%11.43%
Return on Assets
CLPBY
CTEC
BSX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncPpxwnfbllKdhp$141.8 Bil
BDX
Becton Dickinson & CoRvlqyqwWmgklny$71.2 Bil
ALC
Alcon IncJfvlrjvPphvv$41.1 Bil
RMD
ResMed IncJkkbnczzZfbxz$28.9 Bil
WST
West Pharmaceutical Services IncWhrrxwlkwBvj$28.9 Bil
BAX
Baxter International IncMlsrchtgsWdvpwfq$21.7 Bil
COO
The Cooper Companies IncTctgzdpwMlcmrn$20.2 Bil
HOLX
Hologic IncGdtyrxgRqwqq$18.2 Bil
TFX
Teleflex IncTmsqRjf$10.5 Bil

Sponsor Center